Abbott BiologicalsPublic OrganizationNetherlandsInfluenzaSeasonal Influenza; QuadrivalentInfluvacPrimary culture technology2023-05-25T10:33:40 Abbott BiologicalsPublic OrganizationNetherlandsInfluenzaSeasonal Influenza; QuadrivalentInfluvac TetraPrimary culture technology2023-05-25T10:33:40 Abbott BiologicalsPublic OrganizationNetherlandsInfluenzaSeasonal Influenza; TrivalentSerinfluPrimary culture technology2023-05-25T10:33:40 AdimmunePublic OrganizationTaiwan2023-05-25T10:33:40 AJ Vaccine (Staten Serum Institute)Public OrganizationDenmarkIPVIPVIPV Vaccine SSI Mammalian cell culture technology2023-05-25T10:33:40 AJ Vaccine (Staten Serum Institute)Public OrganizationDenmarkIPVIPVPICOVAXMammalian cell culture technology2023-05-25T10:33:40 AMSONPublic OrganizationPakistan2023-05-25T10:33:40 AnGesPublic OrganizationJapan2023-05-25T10:33:40 Anhui Zhifei Longcom BiopharmaceuticalChinaCovid-19Covid-19Zifivax Mammalian cell culture technology2023-05-25T10:33:40 ArabioPublic OrganizationSaudi Arabia2023-05-25T10:33:40 Arcturus TherapeuticsUnited States of America2023-05-25T10:33:40 AstraZenecaPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandCovid-19Covid-19VaxzevriaMammalian cell culture technology2023-05-25T10:33:40 Bavarian NordicPublic OrganizationDenmark2023-05-25T10:33:40 BaxterPublic OrganizationUnited States of America2023-05-25T10:33:40 Beijing Bio-Institute of Biological ProductsPublic OrganizationChinaIPVSabin IPVSabin strain polio inactivated vaccine (Vero cells)Mammalian cell culture technology2023-05-25T10:33:40 Beijing Bio-Institute of Biological ProductsPublic OrganizationChinaMMRMMRMeasles, Mumps and Rubella Combined VaccineMammalian cell culture technology2023-05-25T10:33:40 Beijing MinhaiPublic OrganizationChina2023-05-25T10:33:40 Beijing Zhifei Luzhu BiopharmaceuticalChina2023-05-25T10:33:40 Berna BiotechPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; Trivalentinflexal VPrimary culture technology2023-05-25T10:33:40 Bharat BiotechPublic OrganizationIndiaCovid-19Covid-19CovaxinMammalian cell culture technology2023-05-25T10:33:40 Bharat BiotechPublic OrganizationIndiaRotaRotaRotavacMammalian cell culture technology2023-05-25T10:33:40 Bharat BiotechPublic OrganizationIndiaRotaRotaRotavac 5DMammalian cell culture technology2023-05-25T10:33:40 BikenPublic OrganizationJapan2023-05-25T10:33:40 Bilthoven BiologicalsPublic OrganizationNetherlandsIPVIPVPoliomyelitis vaccineMammalian cell culture technology2023-05-25T10:33:40 BinnopharmPublic OrganizationRussian Federation2023-05-25T10:33:40 BiokangtaiPublic OrganizationChinaCovid-19Covid-19Inactivated SARS-CoV-2 vaccine Mammalian cell culture technology2023-05-25T10:33:40 Biological E. LimitedPublic OrganizationIndia2023-05-25T10:33:40 Bio-Manguinhos/FiocruzPublic OrganizationBrazilIPVIPVVACINAMammalian cell culture technology2023-05-25T10:33:40 Bio-Manguinhos/FiocruzPublic OrganizationBrazilMMRMMRMeasles, mumps and rubella (MMR)Mammalian cell culture technology2023-05-25T10:33:40 Bio-Manguinhos/FiocruzPublic OrganizationBrazilRotaRotaHuman RotavirusMammalian cell culture technology2023-05-25T10:33:40 Bio-MedPublic OrganizationIndia2023-05-25T10:33:40 Biomed LublinPublic OrganizationPoland2023-05-25T10:33:40 Bionet-AsiaPublic OrganizationThailand2023-05-25T10:33:40 BioNTechPublic OrganizationGermany2023-05-25T10:33:40 BioVacPublic OrganizationSouth Africa2023-05-25T10:33:40 BIRMEXPublic OrganizationMexicoInfluenzaSeasonal Influenza; TrivalentInfluenza vaccinePrimary culture technology2023-05-25T10:33:40 BoryungPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentBoryung flu V quadrivalent vaccine inj. Primary culture technology2023-05-25T10:33:40 BoryungPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentBoryung flu VIII tetra vaccine inj.Primary culture technology2023-05-25T10:33:40 BoryungPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentBoryung flu vaccine V inj.Primary culture technology2023-05-25T10:33:40 BoryungPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentBoryung flu vaccine VIII-TF inj.Primary culture technology2023-05-25T10:33:40 BoryungPublic OrganizationSouth KoreaIPVIPVIPVAXMammalian cell culture technology2023-05-25T10:33:40 BravoVaxPublic OrganizationChina2023-05-25T10:33:40 Bul Bio - National Center of Infectious and Parasitic Diseases (BB-NCIPD)Public OrganizationBulgaria2023-05-25T10:33:40 ButantanPublic OrganizationBrazilHPVHPV4Vacina papilomavirus humano tipo, 6, 11, 16 e 18 (recombinante)Microbial-based production platform2023-05-25T10:33:40 ButantanPublic OrganizationBrazilInfluenzaSeasonal Influenza; TrivalentSeasonal Influenza VaccinePrimary culture technology2023-05-25T10:33:40 CanSino BiologicsPublic OrganizationChinaCovid-19Covid-19ConvideciaMammalian cell culture technology2023-05-25T10:33:40 Center for Genetics Engineering and Biotechnology (CIGB)CubaCovid-19Covid-19AbdalaMammalian cell culture technology2023-05-25T10:33:40 Centro de Ingenieria Genetica y Biotecnologia (CIGB)Public OrganizationCuba2023-05-25T10:33:40 Changchun BCHT Biotechnology Public OrganizationChina2023-05-25T10:33:40 Changchun ChangshengPublic OrganizationChinaInfluenzaSeasonal Influenza; QuadrivalentInfluenza quadrivalentPrimary culture technology2023-05-25T10:33:40 Chengdu Institute of Biological ProductsPublic OrganizationChina2023-05-25T10:33:40 Chengdu KanghuaPublic OrganizationChina2023-05-25T10:33:40 China National Biotech Group KeygenUniversityChina2023-05-25T10:33:40 China National Biotech Group LanzhouUniversityChinaRotaRotaLLRMammalian cell culture technology2023-05-25T10:33:40 China National Biotech Group ShanghaiUniversityChinaMMRMMRMeasles, Mumps and Rubella Combined VaccineMammalian cell culture technology2023-05-25T10:33:40 China National Biotech Group TiantanUniversityChina2023-05-25T10:33:40 China National Biotech Group WuhanUniversityChina2023-05-25T10:33:40 Chinese Institute of Medical BiologyChina2023-05-25T10:33:40 Chiron Behring Vaccines PrivatePublic OrganizationIndia2023-05-25T10:33:40 Chumakov Federal Scientific CenterRussian FederationCovid-19Covid-19CoviVacMammalian cell culture technology2023-05-25T10:33:40 Clover Biopharmaceuticals2023-05-25T10:33:40 Commonwealth Serum Laboratories (CSL)Australia2023-05-25T10:33:40 CPL BiologicalsPublic OrganizationIndia2023-05-25T10:33:40 CSL2023-05-25T10:33:40 CureVacPublic OrganizationGermany2023-05-25T10:33:40 Dalian HissenChina2023-05-25T10:33:40 DAVACViet Nam2023-05-25T10:33:40 DynavaxPublic OrganizationUnited States of America2023-05-25T10:33:40 Emergent BioSolutionsPublic OrganizationUnited States of America2023-05-25T10:33:40 Espromed BioPublic OrganizationVenezuela (Bolivarian Republic of)2023-05-25T10:33:40 EuBiologicsPublic OrganizationSouth Korea2023-05-25T10:33:40 Ezequiel Dias Foundation (FUNED)GovernmentBrazil2023-05-25T10:33:40 FarmeksPublic OrganizationUkraine2023-05-25T10:33:40 Finlay Institute of VaccinesCubaCovid-19Covid-19Soberana 2Mammalian cell culture technology2023-05-25T10:33:40 Fosun PharmaChina2023-05-25T10:33:40 Fundacao Ataulpho de Paiva (FAP)Brazil2023-05-25T10:33:40 GamaleyaGovernmentRussian FederationCovid-19Covid-19Sputnik LightMammalian cell culture technology2023-05-25T10:33:40 GamaleyaGovernmentRussian FederationCovid-19Covid-19Sputnik VMammalian cell culture technology2023-05-25T10:33:40 GeneOne Life SciencePublic OrganizationSouth Korea2023-05-25T10:33:40 Gennova BiopharmaceuticalsPublic OrganizationIndia2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVInfanrix HexaFermentation technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVInfanrix HexaMammalian cell culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandHPVHPV2CervarixBaculovirus-insect cell culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; QuadrivalentFluarix Quadrivalent; Fluarix Tetra; Influsplit Tetra (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentFluarix (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandIPVIPVPOLIORIXMammalian cell culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandMMRMMRPriorixMammalian cell culture technology2023-05-25T10:33:40 GlaxoSmithKline Biologicals SAPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandRotaRotaRotarixMammalian cell culture technology2023-05-25T10:33:40 GPO-MBPPublic OrganizationThailandInfluenzaSeasonal Influenza; TrivalentTrivalent inactivated influenza vaccinePrimary culture technology2023-05-25T10:33:40 Green Cross CorporationPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentGCFLU Quadrivalent inj.Primary culture technology2023-05-25T10:33:40 Green Cross CorporationPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentGCFLU Quadrivalent Multi inj.Primary culture technology2023-05-25T10:33:40 Green Cross CorporationPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentGC FLU injPrimary culture technology2023-05-25T10:33:40 Green Cross CorporationPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentGC FLU Multi inj.Primary culture technology2023-05-25T10:33:40 GreenSignal Bio Pharma LimitedPublic OrganizationIndia2023-05-25T10:33:40 Group 42 (G42)2023-05-25T10:33:40 Haffkine Bio PharmaceuticalGovernmentIndia2023-05-25T10:33:40 HLL Biotech LimitedIndia2023-05-25T10:33:40 Hualan Biological BacterinPublic OrganizationChinaInfluenzaSeasonal Influenza; TrivalentInfluenza Vaccine (Split virion, inactivated)Primary culture technology2023-05-25T10:33:40 IBSS BiomedPublic OrganizationPoland2023-05-25T10:33:40 ID Biomedical Corporation of QuebecCanadaInfluenzaSeasonal Influenza; QuadrivalentFluLaval Quadrivalent; Flulaval Tetra (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 ID Biomedical Corporation of QuebecCanadaInfluenzaSeasonal Influenza; TrivalentFlulaval (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Il-Yand PharmaceuticalPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentIL-YANG FLU Vaccine INJ.Primary culture technology2023-05-25T10:33:40 IMBCAMSGovernmentChinaCovid-19Covid-19SAR-CoV-2 vaccineMammalian cell culture technology2023-05-25T10:33:40 IMBCAMSGovernmentChinaIPVSabin IPVInactivated Poliomyelitis Vaccine made from Sabin strains (Vero cells)Mammalian cell culture technology2023-05-25T10:33:40 Imunoloski zavod ZagrebGovernmentCroatia2023-05-25T10:33:40 Incepta PharmaceuticalsPublic OrganizationBangladesh2023-05-25T10:33:40 Indian ImmunologicalsPublic OrganizationIndia2023-05-25T10:33:40 Inovio PharmaceuticalsPublic OrganizationUnited States of America2023-05-25T10:33:40 Institut Pasteur de DakarPublic EnterpriseFrance2023-05-25T10:33:40 Institut Pasteur de TunisPublic EnterpriseTunisia2023-05-25T10:33:40 Institut Pasteur IranPublic EnterpriseIran2023-05-25T10:33:40 Instituto Biológico Argentino S.A.I.C. (BIOL)Public OrganizationArgentina2023-05-25T10:33:40 IntervaxPublic OrganizationCanada2023-05-25T10:33:40 IVACGovernmentViet Nam2023-05-25T10:33:40 Janssen PharmaceuticalsPublic OrganizationBelgiumCovid-19Covid-19Ad26.COV2.S Mammalian cell culture technology2023-05-25T10:33:40 Japan BCG LaboratoryPublic OrganizationJapan2023-05-25T10:33:40 Korea VaccinePublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentKovax-flu; Kovax-InfluPrimary culture technology2023-05-25T10:33:40 Korea VaccinePublic OrganizationSouth KoreaIPVIPVKOVAX POLIO PF Inj.Mammalian cell culture technology2023-05-25T10:33:40 LG ChemPublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentFluplus Tf Inj.Primary culture technology2023-05-25T10:33:40 LG ChemPublic OrganizationSouth KoreaIPVSabin IPVEupolio Inj.Mammalian cell culture technology2023-05-25T10:33:40 Liaoning Chengda Biotechnology (CDBIO)Public OrganizationChina2023-05-25T10:33:40 M. Aikimbayev Kazakh Scientific Center of Quarantine and Zoonotic Diseases (KSCQZD)GovernmentKazakhstan2023-05-25T10:33:40 MassBiologicsPublic OrganizationUnited States of America2023-05-25T10:33:40 MedicagoPublic OrganizationUnited States of America2023-05-25T10:33:40 Medigen Vaccine BiologicsGovernmentTaiwanCovid-19Covid-19MVC-COV19012023-05-25T10:33:40 MedImmuneUnited States of AmericaInfluenzaSeasonal Influenza; QuadrivalentFluMist Quadrivalent; Fluenz Tetra (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 MedImmuneUnited States of AmericaInfluenzaSeasonal Influenza; TrivalentFluMist; Fluenz (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVVaxelisFermentation technology2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVVaxelisMammalian cell culture technology2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaHPVHPV4GardasilMicrobial-based production platform2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaHPVHPV9Gardasil 9Microbial-based production platform2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaMMRMMRrHA M-M-R IIMammalian cell culture technology2023-05-25T10:33:40 Merck Sharp & Dohme (MSD)Public OrganizationUnited States of AmericaRotaRotaRotateqMammalian cell culture technology2023-05-25T10:33:40 MicrogenGovernmentRussian FederationInfluenzaSeasonal Influenza; TrivalentGrippolPrimary culture technology2023-05-25T10:33:40 MicrogenGovernmentRussian FederationInfluenzaSeasonal Influenza; TrivalentSovigrippPrimary culture technology2023-05-25T10:33:40 Ministry of Defense, RussiaGovernmentRussian Federation2023-05-25T10:33:40 ModernaPublic OrganizationUnited States of AmericaCovid-19Covid-19Spikevax2023-05-25T10:33:40 NANOLEKPublic OrganizationRussian FederationIPVIPVPolymilexMammalian cell culture technology2023-05-25T10:33:40 North China Pharmaceutical Group Corp. (NCPC)China2023-05-25T10:33:40 NovartisPublic OrganizationSwitzerlandInfluenzaSeasonal Influenza; TrivalentBegrivacPrimary culture technology2023-05-25T10:33:40 NovavaxPublic OrganizationUnited States of America2023-05-25T10:33:40 Nuron BiotechPublic OrganizationUnited States of America2023-05-25T10:33:40 Panacea BiotecPublic OrganizationIndiaDTwP-HepB-Hib-IPVDTwP-HepB-Hib-IPVEasySixFermentation technology2023-05-25T10:33:40 Panacea BiotecPublic OrganizationIndiaDTwP-HepB-Hib-IPVDTwP-HepB-Hib-IPVEasySixMammalian cell culture technology2023-05-25T10:33:40 Panacea BiotecPublic OrganizationIndiaIPVIPVPOLPROTECMammalian cell culture technology2023-05-25T10:33:40 Pasteur Institute of IndiaGovernmentIndia2023-05-25T10:33:40 PaxVaxPublic OrganizationUnited States of America2023-05-25T10:33:40 PetrovaxPublic OrganizationRussian FederationInfluenzaSeasonal Influenza; QuadrivalentGrippol QuadrivalentPrimary culture technology2023-05-25T10:33:40 PetrovaxPublic OrganizationRussian FederationInfluenzaSeasonal Influenza; TrivalentGrippol NeoPrimary culture technology2023-05-25T10:33:40 PetrovaxPublic OrganizationRussian FederationInfluenzaSeasonal Influenza; TrivalentGrippol PlusPrimary culture technology2023-05-25T10:33:40 PfizerPublic OrganizationUnited States of America2023-05-25T10:33:40 Pfizer/BioNTechGermanyCovid-19Covid-19Comirnaty2023-05-25T10:33:40 POLYVACGovernmentViet NamRotaRotaRotavin-M1Mammalian cell culture technology2023-05-25T10:33:40 Protein Sciences CorporationUnited States of AmericaInfluenzaSeasonal Influenza; TrivalentFlublok (Northern hemisphere)Baculovirus-insect cell culture technology2023-05-25T10:33:40 Providence TherapeuticsCanada2023-05-25T10:33:40 PT Bio Farma (Persero)UniversityIndonesiaIPVIPVInactivated polio vaccine (IPV, Bulk from Sanofi Pasteur SA)Mammalian cell culture technology2023-05-25T10:33:40 Razi InstitutePublic OrganizationIranMMRMMRMMRMammalian cell culture technology2023-05-25T10:33:40 Research Institute for Biological Safety ProblemsKazakhstanCovid-19Covid-19QazCovid-inMammalian cell culture technology2023-05-25T10:33:40 Saint-Petersburg Scientific Research Institute of vaccines and sera (SPbSRIVS)GovernmentRussian Federation2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceDengueDengueDengvaxia2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceDengueDengueDENGVAXIA TESTother2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVHexavac, Hexaxim, HexyonFermentation technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceDTaP-HepB-Hib-IPVDTaP-HepB-Hib-IPVHexavac, Hexaxim, HexyonMammalian cell culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentFlublok Quadrivalent (Northern hemisphere)Baculovirus-insect cell culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentFluzone High-Dose Quadrivalent (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentFluzone Intradermal QuadrivalentPrimary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentFluzone Quadrivalent (Southern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentFluzone Quadrivalent; FluQuadri (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; QuadrivalentVaxigripTetraPrimary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; TrivalentFluzone (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; TrivalentFluzone (Southern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; TrivalentFluzone High-Dose Trivalent (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; TrivalentFluzone Intradermal TrivalentPrimary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceInfluenzaSeasonal Influenza; TrivalentVaxigripPrimary culture technology2023-05-25T10:33:40 Sanofi PasteurPublic OrganizationFranceIPVIPVIMOVAX POLIOMammalian cell culture technology2023-05-25T10:33:40 Sanofi Pasteur/GSKFrance2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; QuadrivalentAfluria Quadrivalent (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; QuadrivalentAfluria Quadrivalent (Southern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; QuadrivalentFluad Quadrivalent (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; QuadrivalentFlucelvax QuadrivalentMammalian cell culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentAfluria (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentAfluria (Southern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentAgrifluPrimary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentAgrippal; Agrippal S1; Chiroflu; Begripal; SandovacPrimary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentFluad (Northern hemisphere)Primary culture technology2023-05-25T10:33:40 Seqirus LimitedPublic OrganizationUnited Kingdom of Great Britain and Northern IrelandInfluenzaSeasonal Influenza; TrivalentFluvirinPrimary culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaCovid-19Covid-19CovishieldMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaInfluenzaSeasonal Influenza; TrivalentNasovac-S Influenza Vaccine, Live, Attenuated (Human)Primary culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaIPVIPVPOLIOVACMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaIPVIPVPOLIOVAC PFSMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaMMRMMRMeasles,Mumps and Rubella Vaccine Live attenuatedMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaRotaRotaRotasiilMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaRotaRotaRotasiil ThermoMammalian cell culture technology2023-05-25T10:33:40 Serum Institute of IndiaPublic OrganizationIndiaRotaRotaRotasiil-liquidMammalian cell culture technology2023-05-25T10:33:40 Sevapharma A.SPublic OrganizationCzechiaMMRMMRTRIVIVACMammalian cell culture technology2023-05-25T10:33:40 Shanghai Institute of Biological ProductsChinaInfluenzaSeasonal Influenza; TrivalentInfluenza virus split vaccinePrimary culture technology2023-05-25T10:33:40 Shantha BiotechnicsPublic OrganizationIndiaIPVIPVShanIPVMammalian cell culture technology2023-05-25T10:33:40 Shifa PharmedIranCovid-19Covid-19CovIran Barekat2023-05-25T10:33:40 Siam BiosciencePublic OrganizationThailandCovid-19Covid-19COVID-19 Vaccine (ChAdOx1-S [recombinant])Mammalian cell culture technology2023-05-25T10:33:40 Sinergium BiotechPublic OrganizationArgentinaHPVHPV4Silgard VPHMicrobial-based production platform2023-05-25T10:33:40 Sinergium BiotechPublic OrganizationArgentinaInfluenzaSeasonal Influenza; TrivalentFluxvirPrimary culture technology2023-05-25T10:33:40 Sinergium BiotechPublic OrganizationArgentinaInfluenzaSeasonal Influenza; TrivalentVirafluPrimary culture technology2023-05-25T10:33:40 SinopharmUniversityChinaMMRMMRMeasles, Mumps and Rubella Combined VaccineMammalian cell culture technology2023-05-25T10:33:40 Sinovac BiotechPublic OrganizationChinaCovid-19Covid-19CoronaVacMammalian cell culture technology2023-05-25T10:33:40 SK BiosciencePublic OrganizationSouth KoreaCovid-19Covid-19COVID-19 Vaccine (ChAdOx1-S [recombinant])Mammalian cell culture technology2023-05-25T10:33:40 SK BiosciencePublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentSKYCellflu Quadrivalent inj.Mammalian cell culture technology2023-05-25T10:33:40 SK BiosciencePublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; QuadrivalentSKYCellflu Quadrivalent Multi inj.Mammalian cell culture technology2023-05-25T10:33:40 SK BiosciencePublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentSKYCellflu inj.Mammalian cell culture technology2023-05-25T10:33:40 SK BiosciencePublic OrganizationSouth KoreaInfluenzaSeasonal Influenza; TrivalentSKYCellflu Multi inj.Mammalian cell culture technology2023-05-25T10:33:40 State Research Center of Virology and Biotechnology (VECTOR)GovernmentRussian FederationCovid-19Covid-19EpiVacCoronaNucleic acid-based technology2023-05-25T10:33:40 Staten Serum InstituteDenmark2023-05-25T10:33:40 Takeda PharmaceuticalJapan2023-05-25T10:33:40 Thai Red CrossGovernmentThailand2023-05-25T10:33:40 The Government Pharmaceutical Organization (GPO)GovernmentThailand2023-05-25T10:33:40 TorlakGovernmentSerbia2023-05-25T10:33:40 VABIOTECHUniversityViet Nam2023-05-25T10:33:40 VacseraPublic OrganizationEgypt2023-05-25T10:33:40 ValnevaPublic OrganizationFrance2023-05-25T10:33:40 VaxartPublic OrganizationUnited States of America2023-05-25T10:33:40 VaxinePublic OrganizationAustralia2023-05-25T10:33:40 Vaxxinity2023-05-25T10:33:40 Vector-BiAlgam2023-05-25T10:33:40 VINS BioproductsPublic OrganizationIndia2023-05-25T10:33:40 WalvaxPublic OrganizationChina2023-05-25T10:33:40 Xiamen Innovax BiotechPublic OrganizationChinaHPVHPV2CecolinMicrobial-based production platform2023-05-25T10:33:40 Zhejiang PukangPublic OrganizationChina2023-05-25T10:33:40 Zhifei Biological ProductsPublic OrganizationChina2023-05-25T10:33:40 Zydus CadilaPublic OrganizationIndiaCovid-19Covid-19ZyCoV-D2023-05-25T10:33:40